• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
41 to 50 of 65 Results
Analyte Buprenorphine Complexity waived Effective Date To 10/22/2014
 < 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 > 
Results per Page

New Search
Export all 65 records to ExcelExport to Excel | Help | Download Files
Document Parent Analyte Analyte Specialty Effective Date
American Screening Corporation One Screen Drug Test Cards  
K130463   Buprenorphine Toxicology / TDM 08/15/2013
American Screening Corporation Reveal Multi-Drug Testing Cups  
K130463   Buprenorphine Toxicology / TDM 08/15/2013
UCP Biosciences, Inc. Multiple Drug Screen Cups  
K130463   Buprenorphine Toxicology / TDM 08/15/2013
Alere iScreen DX Multi-Drugs of Abuse Dip Test  
K022355   Buprenorphine Toxicology / TDM 08/01/2013
Alere iCup Dx 14  (Cassette Dip Card format)
K122633   Buprenorphine Toxicology / TDM 07/29/2013
UCP Biosciences, Inc. UCP Compact Drug Test Cards  
K131811   Buprenorphine Toxicology / TDM 07/19/2013
UCP Biosciences, Inc. UCP Compact Drug Test Cups  
K131811   Buprenorphine Toxicology / TDM 07/19/2013
Cliawaived Inc. Instant Drug Test Cup  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
Cliawaived Inc. Drug of Abuse Card  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
US Diagnostics Inc. UScreen Drugs of Abuse Card  
K130665   Buprenorphine Toxicology / TDM 05/29/2013

-
-